| Patents for C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149) |
|---|
| 06/09/2005 | US20050124606 Novel benzothiazine and benzothiadiazine derivatives method for preparing same and pharmaceutical compositions containing same |
| 06/09/2005 | US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions |
| 06/08/2005 | EP1538150A1 Novel pleuromutilin derivatives |
| 06/07/2005 | US6903115 Bipiperidine compounds |
| 06/07/2005 | US6903097 Heterocycle carboxamides as antiviral agents |
| 06/02/2005 | WO2005049589A2 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases |
| 06/02/2005 | WO2005049561A2 Processes for preparing novel methylene blue derivative |
| 06/02/2005 | US20050119461 Which have affinity for oxazoline compounds; for treatment of glaucoma, dementia, mood disturbances, degenerative conditions, and neurodegenerative diseases |
| 06/02/2005 | US20050119257 Cyclic sulfone containing retroviral protease inhibitors |
| 06/01/2005 | EP1534690A1 2-substituted bicyclic benzoheterocyclic compounds and their use as sodium channel blockers |
| 06/01/2005 | EP1534346A2 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues |
| 06/01/2005 | EP1351959B1 Novel pleuromutilin derivatives |
| 05/31/2005 | US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis |
| 05/31/2005 | US6900218 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 05/26/2005 | US20050113575 Nile red luminescent comp0und emitting red light, process for producing the same, and luminescent element utilizing the same |
| 05/26/2005 | US20050113566 Inhibitors of C-FMS kinase |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113368 eg (+-) Ethyl 3-[4-{3-(3,4-dihydro-2H-benzo[b][1,4]oxazin-4-yl)propylamino}phenyl]-2-ethoxypropanoate; antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic |
| 05/26/2005 | US20050113346 making sulfur compounds such as 2-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-N-hydroxy-3-methyl -butyramide, used as tumor necrosis factor-alpha converting enzyme (TACE) inhibitors, for prophylaxis of rheumatic diseases, sepsis or inflammation |
| 05/25/2005 | EP1532623A1 Materials for optical medium copy-protection transiently reacting to a reader beam |
| 05/25/2005 | CN1620441A Nile red type compound emitting red light, process for producing the same, and luminescent element utilizing the same |
| 05/24/2005 | US6897199 Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds |
| 05/24/2005 | US6896891 Non-systemic control of parasites |
| 05/19/2005 | WO2005044201A2 Ph sensitive prodrugs of 2,6-diisopropylphenol |
| 05/19/2005 | US20050107607 Processes for preparing novel methylene blue derivative |
| 05/19/2005 | CA2543166A1 Ph sensitive prodrugs of 2,6-diisopropylphenol |
| 05/18/2005 | CN1201820C Compositions containing benzimidazolones and progestogens |
| 05/17/2005 | US6894005 Heterocyclic compound containing phenyl groups; postemergence herbicides |
| 05/17/2005 | CA2103845C 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines |
| 05/12/2005 | WO2005023765A8 Method for catalyzing amidation reactions by the presence of co2 |
| 05/12/2005 | US20050101590 Cannabinoid receptor agonists |
| 05/11/2005 | EP1530093A2 Organophotoreceptor with charge transport material with a hydrazone group linked to a heterocyclic group |
| 05/10/2005 | US6890937 Inhibiting the activity of one or more of MMP-2, MMP-9 and MMP-13, while exhibiting substantially less inhibitory activity against MMP-1 |
| 05/06/2005 | WO2005040104A1 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| 05/06/2005 | WO2004092116A8 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 05/06/2005 | CA2538630A1 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| 05/05/2005 | US20050096357 Antibiotics; therapy for infections which is caused by drug-resistant Streptococcus, or bacteria infections |
| 05/05/2005 | US20050095519 Organophotoreceptor with charge transport material with a hydrazone group linked to a heterocyclic group |
| 05/04/2005 | EP1528055A2 Sulphonamide Derivatives |
| 05/04/2005 | EP1527054A1 Substituted thiazines as material protecting agents |
| 05/04/2005 | CN1612058A Organophotoreceptor with charge transport material with a hydrazone group linked to a heterocyclic group |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 04/27/2005 | CN1610661A Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/26/2005 | CA2213124C Benzoyl derivatives |
| 04/21/2005 | WO2005035511A1 N-desmethyl levomepromazine |
| 04/19/2005 | US6881840 Useful in imaging elements including silver halide photographic materials and inkjet materials; do not cause undesirable fluorescence |
| 04/14/2005 | WO2004094396A3 Dihydrothiazine prodrugs of thiazolium agents |
| 04/14/2005 | US20050080076 N-desmethyl levomepromazine |
| 04/13/2005 | CN1606560A Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, their use and pharmaceutical compositions containing same |
| 04/13/2005 | CN1606559A Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, their use and pharmaceutical compositions containing same |
| 04/13/2005 | CN1606550A Benzothia(dia)zine derivatives and their use as AMPA modulators |
| 04/07/2005 | WO2005030794A2 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | WO2005030676A1 Methods of [11c]-radiolabelling phenothiazine and phenothiazine-like compounds |
| 04/07/2005 | US20050075332 Tricyclic compounds with antiviral activity |
| 04/07/2005 | US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials |
| 04/07/2005 | CA2540827A1 Methods of [11c]-radiolabelling phenothiazine and phenothiazine-like compounds |
| 04/07/2005 | CA2539823A1 Hemiasterlin derivatives and uses thereof |
| 04/05/2005 | US6875790 Viricides |
| 03/24/2005 | WO2005026208A2 Chimeric gabab receptor |
| 03/24/2005 | WO2005026138A1 2-naphthylimino-1,3-thiazine derivative |
| 03/24/2005 | WO2005026127A1 Plasminogen activator inhibitor-1 inhibitor |
| 03/24/2005 | US20050065146 Cognition activators; neurodegenerative diseases; anxiolytic agents;psychological disorders; alzheimer's disease; Huntington's disease; antiischemic agents; antiepileptic agenst |
| 03/24/2005 | CA2535221A1 Chimeric gabab receptor |
| 03/23/2005 | CN1599730A Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 03/22/2005 | CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same |
| 03/17/2005 | WO2005023765A1 Method for catalyzing amidation reactions by the presence of co2 |
| 03/17/2005 | US20050059824 Using carbon dioxide; salt formation, hydrolysis |
| 03/17/2005 | US20050059699 N-acylated lipophilic amino acid derivatives |
| 03/16/2005 | CN1596249A Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them |
| 03/16/2005 | CN1596141A Conjugated anti-psychotic drugs and uses thereof |
| 03/10/2005 | WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/10/2005 | WO2004096795A3 C-fms kinase inhibitors |
| 03/10/2005 | US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 03/10/2005 | CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/08/2005 | US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases |
| 03/08/2005 | US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy |
| 03/08/2005 | US6864250 N-acylated lipophilic amino acid derivatives |
| 03/02/2005 | CN1589258A Novel beta -phenyl- alpha -oxysubstituted propionic derivatives: process for their preparation and their use in the preparation of pharmaceutically important compounds |
| 02/24/2005 | WO2005016351A1 Novel use of cannabinoid receptor agonist |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/23/2005 | CN1583732A Preparation of 2-cyanophenthiazine |
| 02/22/2005 | US6858741 Use as pesticides and herbicides |
| 02/17/2005 | US20050038255 Stereoselective preparation of cyclic l-amino acids |
| 02/17/2005 | US20050038021 2,4,5,-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 02/10/2005 | WO2005011611A2 Bicyclic compounds and compositions as pdf inhibitors |
| 02/10/2005 | CA2533824A1 Bicyclic compounds and compositions as pdf inhibitors |
| 02/09/2005 | CN1578910A Neurofibrillary labels |
| 02/09/2005 | CN1578663A Inhibitors of histone deacetylase |
| 02/09/2005 | CN1188173C Vivo stain composition, process of manufacture, methods for identifying dysplastic tissue |
| 02/03/2005 | US20050026194 Using overexpression of relaxin-3 and somatostatin and angiotensin-like peptide receptor (SALPR) as diagnostic indicator of cell proliferative disorders |
| 02/02/2005 | CN1573599A Novel charge transport materials having heteroaromatic hydrazone groups |
| 02/02/2005 | CN1187342C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 02/01/2005 | US6849739 N-heterocyclic derivatives as NOS inhibitors |
| 02/01/2005 | US6849732 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 02/01/2005 | US6849648 Phenylene alkyne matrix metalloproteinase inhibitors |
| 01/27/2005 | WO2004091613A3 Substituted phenyl acetamides and their use as protease inhibitors |
| 01/27/2005 | WO2004029672A3 Transient optical state change materials useful in copy-protected compact discs |
| 01/26/2005 | EP1500402A1 Cell death inhibitor |
| 01/26/2005 | CN1186333C 1-(alpha-aminobenzyl)-2 naphthol ketal (acetal) compound and its preparation and use |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |